From: A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer
chromosomal region | fraction of patients | congruence with our expression data | CGH study |
---|---|---|---|
1 | Â | no | [18] |
1q21 | 57% | no | [21] |
3p25.2 | 30% | yes | [25] |
3q26.31 | 32% | no | [25] |
6p12.1 | 24% | no | [25] |
7 | 46% | yes | [17, 18, 25] |
7p | > 35% | yes | [23] |
7p | 42% | yes | [19] |
7p22.3 | 57% | yes | [25] |
7q | 42% | yes | [19] |
7q | > 35% | yes | [23] |
7q11.2-7q12 | 75% | 7q11.23-7q21.3 | [21, 24] |
8q | Â | yes | [17] |
8q | 27% | yes | [18, 25] |
8q | 42% | yes | [23] |
8q24 | 57% | yes | [21] |
8q24.21 | 40% | yes | [25] |
8q24.22 | 30% | yes | [25] |
8q24.3 | 51% | yes | [25] |
9q34 | 67% | 9q31.11 | [21, 24] |
11q | > 35% | yes | [23] |
12p13.1-12p13.2 | 22% | down at 12p13.31-12p13-2 | [25] |
13 | Â | yes | [18] |
13 | 46% | yes | [25] |
13q | Â | yes | [17] |
13q13 | 64% | no | [21, 24] |
13q34 | 64% | no | [21] |
15q22-15q23 | Â | down at 15q21.1-15q22.31 | [22] |
16p12-11 | 70% | down at 16p12.1-16p11.2 | [21, 24] |
16p13.3 | 49% | no | [25] |
16q23.2 | 24% | no | [25] |
17q | 42% | yes | [19] |
17q12-17q21 | Â | yes | [24] |
17q12 | 22% | no | [25] |
17q21 | 59% | yes | [21] |
17q21.32 | 24% | yes | [25] |
17q25.3 | 43% | no | [25] |
19p13 | 70% | yes | [21, 24] |
20 | Â | yes | [18, 25] |
20p | 58% | yes | [19] |
20q | Â | yes | [17] |
20q | 65% | yes | [23] |
20q | 100% | yes | [21] |
20q | 92% | yes | [19] |
20q13.3 | 56% | yes | [22] |
20q13.3 | 81% | yes | [25] |
20q11.2-20q13.2 | Â | yes | [24] |
22q11 | 61% | 22q11.21-22q21.1 | [21] |
22q13.2 | 24% | no | [25] |